Carrick Therapeutics
2015
FOUNDED
PRIVATE
STATUS
Series A
LATEST DEAL TYPE
$95M
LATEST DEAL AMOUNT
7
INVESTORS
Description
Developer of cancer therapeutics intended to target molecular pathways that drive the most aggressive and resistant forms of cancer. The company's cancer therapeutics are innovative first-in-class mechanisms, enabling cancer patients to get their predictive biomarkers detected and get their treatments started from the first stage.
Website
Formerly Known As
Navillus Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Devices and Supplies
Therapeutic Devices
Primary Office
- Belfield Innovation Park
- University College Dublin, Belfield
- Dublin 4
- Ireland
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Carrick Therapeutics’s full profile, request a free trial.
Carrick Therapeutics Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC (Series A) | 03-Oct-2016 | $95M | 0000 | Completed | Startup |
Carrick Therapeutics Competitors (24)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Aura Biosciences | Venture Capital-Backed | Cambridge, MA | 00 | 00000 | 00000000000 | 00000 |
| 00000000000 | Angel-Backed | Culver City, CA | 00000 | 000000000000 | 00000 | |
| 000000000 | Venture Capital-Backed | Rockville, MD | 000.00 | 0000000000 0 | 000.00 | |
| 0000 000000 | Formerly VC-backed | Santa Monica, CA | 000 | 00000 | 000000&0 | 00000 |
| 00000000 | Venture Capital-Backed | Waltham, MA | 0 | 000.00 | 00000000000 | 000.00 |
Carrick Therapeutics Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| ARCH Venture Partners | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Cambridge Enterprise | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Cambridge Innovation Capital | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Evotec | Corporation | Minority | 000 0000 | 000000 0 | ||
| GV | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |
Carrick Therapeutics Executive Team (4)
Carrick Therapeutics Board Members (9)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Burt Adelman MD | Self | Board Member | 000 0000 | |
| Clive Dix Ph.D | Self | Board Member | 000 0000 | |
| Elaine Sullivan Ph.D | Carrick Therapeutics | Co-Founder, Chief Executive Officer & Board Member | 000 0000 | |
| George Golumbeski Ph.D | Self | Chairman | 000 0000 | |
| Jason Lettmann | Lightstone Ventures | Board Member | 000 0000 |